Serum biomarkers for the assessment of muscle damage in various surgical approaches in primary total hip arthroplasty: a systematic review of comparative studies.
Biomarkers
Minimally invasive surgery
Muscle damage
Tissue damage
Tissue inflammation
Total hip arthroplasty
Journal
International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
26
04
2022
accepted:
10
05
2022
pubmed:
1
6
2022
medline:
6
8
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Using serum biomarkers, this systematic review assessed soft tissue injury following different total hip arthroplasty surgical approaches. The purposes were to determine if there is any advantage between the standard and minimal invasive approaches, and to compare tissue damage of the respective surgical approaches using biomarkers such as creatine kinase, myoglobin, c-reactive protein, erythrocyte sedimentation rate, skeletal troponin and interleukins. A search in Pubmed/MEDLINE, Scopus and Web of Science databases was conducted in October 2021 with the use of PRISMA guidelines. Search items were ("biomarkers" OR "markers" OR "tissue damage" OR "muscle damage") AND "approach" AND ("total hip arthroplasty" OR "total hip replacement"). Inclusion criteria were prospective, randomized, controlled trials or prospective, comparative studies, comparing serum markers for muscle damage in two or more surgical approaches for primary total hip arthroplasty. Exclusion criteria were study protocols, case reports, systematic reviews, meta-analyses, studies in non-English language or without available full text, and studies not recording biomarkers of muscle damage. Initial search revealed 508 studies; after subtraction of duplicates, and exclusion criteria, 31 studies remained for analysis. No advantage between different approaches was found when evaluating biomarkers, and no specific biomarkers had a distinct role in tissue damage in total hip arthroplasty. Anterior and minimally invasive approaches were associated with lower values of soft tissue (creatine kinase) and inflammation (c-reactive protein) biomarkers compared to the standard approaches. Measurement of serum biomarkers after primary total hip arthroplasty for the estimation of tissue damage has unclear or little clinical value. PROSPERO Registration: CRD42022303959.
Identifiants
pubmed: 35641792
doi: 10.1007/s00264-022-05442-w
pii: 10.1007/s00264-022-05442-w
doi:
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Creatine Kinase
EC 2.7.3.2
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1681-1692Informations de copyright
© 2022. The Author(s) under exclusive licence to SICOT aisbl.
Références
Galia CR, Diesel CV, Guimarães MR, Ribeiro TA (2017) Total hip arthroplasty: a still evolving technique. Rev Bras Ortop 52(5):521–527
pubmed: 29062814
pmcid: 5643983
Aggarwal VK, Iorio R, Zuckerman JD, Long WJ (2020) Surgical approaches for primary total hip arthroplasty from Charnley to now: the quest for the best approach. JBJS Rev 8(1):e0058
pubmed: 32105236
Petis S, Howard JL, Lanting BL, Vasarhelyi EM (2015) Surgical approach in primary total hip arthroplasty: anatomy, technique and clinical outcomes. Can J Surg 58(2):128–139
pubmed: 25799249
pmcid: 4373995
Post ZD, Orozco F, Diaz-Ledezma C, Hozack WJ, Ong A (2014) Direct anterior approach for total hip arthroplasty: indications, technique, and results. J Am Acad Orthop Surg 22(9):595–603
pubmed: 25157041
Hardinge K (1982) The direct lateral approach to the hip. J Bone Joint Surg Br 64(1):17–19
pubmed: 7068713
Chen D, Berger RA (2013) Outpatient minimally invasive total hip arthroplasty via a modified Watson-Jones approach: technique and results. Instr Course Lect 62:229–236
pubmed: 23395028
Migliorini F, Biagini M, Rath B, Meisen N, Tingart M, Eschweiler J (2019) Total hip arthroplasty: minimally invasive surgery or not? Meta-analysis of clinical trials. Int Orthop 43(7):1573–1582
pubmed: 30171273
Miller LE, Gondusky JS, Bhattacharyya S, Kamath AF, Boettner F, Wright J (2018) Does surgical approach affect outcomes in total hip arthroplasty through 90 days of follow-up? A systematic review with meta-analysis. J Arthroplasty 33(4):1296–1302
pubmed: 29195848
Murphy SB (2004) Tissue-Preserving, Minimally invasive total hip arthroplasty using a superior capsulotomy. In: Hozack WJ, Krismer M, Nogler M, Bonutti PM, Rachbauer F, Schaffer JL, et al., editors. Minimally invasive total joint arthroplasty. Berlin, Heidelberg: Springer Berlin Heidelberg p. 101–7
Penenberg BL, Bolling WS, Riley M (2008) Percutaneously assisted total hip arthroplasty (PATH): a preliminary report. J Bone Joint Surg Am 90(Suppl 4):209–220
pubmed: 18984733
Moreau P (2018) Minimally invasive total hip arthroplasty using Hueter’s direct anterior approach. Eur J Orthop Surg Traumatol 28(5):771–779
pubmed: 29511824
Bertin KC, Rottinger H (2004) Anterolateral mini-incision hip replacement surgery: a modified Watson-Jones approach. Clin Orthop Relat Res 429:248–255
Ilchmann T (2014) Approaches for primary total hip replacement. Hip Int 2(24 Suppl 10):S2-6
Pfirrmann CW, Notzli HP, Dora C, Hodler J, Zanetti M (2005) Abductor tendons and muscles assessed at MR imaging after total hip arthroplasty in asymptomatic and symptomatic patients. Radiology 235(3):969–976
pubmed: 15860673
Twair A, Ryan M, O’Connell M, Powell T, O’Byrne J, Eustace S (2003) MRI of failed total hip replacement caused by abductor muscle avulsion. AJR Am J Roentgenol 181(6):1547–1550
pubmed: 14627571
Baird MF, Graham SM, Baker JS, Bickerstaff GF (2012) Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metabol 2012:960363
Markert CL (1984) Lactate dehydrogenase. Biochemistry and function of lactate dehydrogenase. Cell Biochem Funct 2(3):131–134
Silverstein TP, Kirk SR, Meyer SC, McFarlane Holman KL (2015) Myoglobin structure and function: a multiweek biochemistry laboratory project. Biochem Mol Biol Educ 43(3):181–188
pubmed: 25726810
Gamblin SJ, Davies GJ, Grimes JM, Jackson RM, Littlechild JA, Watson HC (1991) Activity and specificity of human aldolases. J Mol Biol 219(4):573–576
pubmed: 2056525
Brancaccio P, Lippi G, Maffulli N (2010) Biochemical markers of muscular damage. Clin Chem Lab Med 48(6):757–767
pubmed: 20518645
Germolec DR, Shipkowski KA, Frawley RP, Evans E (2018) Markers of inflammation. Methods Mol Biol 1803:57–79
pubmed: 29882133
Bergin PF, Doppelt JD, Kephart CJ, Benke MT, Graeter JH, Holmes AS, Haleem-Smith H, Tuan RS, Unger AS (2011) Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. JBJS Am 93(15):1392–1398
pubmed: 21915544
pmcid: 3143583
Yu H-r, Li Z-y, Jing J-h, Tang J, Cao Q-l, Cheng W-d (2020) A prospective randomized study comparing the direct anterior approach in the lateral decubitus position versus the standard posterolateral approach for total hip arthroplasty. Acta Orthop Belg 86:181–190
Poehling-Monaghan KL, Taunton MJ, Kamath AF, Trousdale RT, Sierra RJ, Pagnano MW (2017) No correlation between serum markers and early functional outcome after contemporary THA. Clin Orthop Relat Res 475(2):452–462
pubmed: 27233505
Zhao HY, Kang PD, Xia YY, Shi XJ, Nie Y, Pei FX (2017) Comparison of early functional recovery after total hip arthroplasty using a direct anterior or posterolateral approach: a randomized controlled trial. J Arthroplasty 32(11):3421–3428
pubmed: 28662957
Pilot P, Kerens B, Draijer WF, Kort NP, ten Kate J, Buurman WA, Kuipers H (2006) Is minimally invasive surgery less invasive in total hip replacement? A pilot study. Injury 37(SUPPL 5):S17–S23
pubmed: 17338907
Rykov K, Reininga IHF, Sietsma MS, Knobben BAS, Ten Have BLEF (2017) Posterolateral vs direct anterior approach in total hip arthroplasty (POLADA trial): a randomized controlled trial to assess differences in serum markers. J Arthroplasty 32(12):3652–8.e1
pubmed: 28780222
Maezawa K, Nozawa M, Gomi M, Sugimoto M, Maruyama Y (2020) Changes in serum creatine kinase and C-reactive protein after posterior and direct anterior approaches in total hip arthroplasty. Hip Int 8:1120700020978643
De Anta-Díaz B, Serralta-Gomis J, Lizaur-Utrilla A, Benavidez E, López-Prats FA (2016) No differences between direct anterior and lateral approach for primary total hip arthroplasty related to muscle damage or functional outcome. Int Orthop 40(10):2025–2030
pubmed: 26753844
Nistor DV, Caterev S, Bolboacă SD, Cosma D, Lucaciu DOG, Todor A (2017) Transitioning to the direct anterior approach in total hip arthroplasty. Is it a true muscle sparing approach when performed by a low volume hip replacement surgeon? Int Orthop 41(11):2245–2252
Nistor DV, Bota NC, Caterev S, Todor A (2020) Are physical therapy pain levels affected by surgical approach in total hip arthroplasty? A randomized controlled trial. Orthop Rev (Pavia) 12(1):8399
Iorio R, Viglietta E, Mazza D, Iannotti F, Nicolosi I, Carrozzo A, Speranza A, Ferretti A (2021) Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches. Orthop Traumatol Surg Res 107(8):102937
pubmed: 33895386
Mjaaland KE, Kivle K, Svenningsen S, Pripp AH, Nordsletten L (2015) Comparison of markers for muscle damage, inflammation, and pain using minimally invasive direct anterior versus direct lateral approach in total hip arthroplasty: a prospective, randomized, controlled trial. J Orthop Res 33(9):1305–1310
pubmed: 25877694
Inaba Y, Kobayashi N, Yukizawa Y, Ishida T, Iwamoto N, Saito T (2011) Little clinical advantage of modified Watson-Jones approach over modified mini-incision direct lateral approach in primary total hip arthroplasty. J Arthroplast 26(7):1117–1122
Matziolis D, Wassilew G, Strube P, Matziolis G, Perka C (2011) Differences in muscle trauma quantifiable in the laboratory between the minimally invasive anterolateral and transgluteal approach. Arch Orthop Trauma Surg 131(5):651–655
pubmed: 20953874
Landgraeber S, Quitmann H, Guth S, Haversath M, Kowalczyk W, Kecskeméthy A, Heep H, Jäger M (2013) H A prospective randomized peri- and post-operative comparison of the minimally invasive anterolateral approach versus the lateral approach. Orthop Rev (Pavia) 5(3):e19
Müller M, Tohtz S, Springer I, Dewey M, Perka C (2011) Randomized controlled trial of abductor muscle damage in relation to the surgical approach for primary total hip replacement: minimally invasive anterolateral versus modified direct lateral approach. Arch Orthop Trauma Surg 131(2):179–189
pubmed: 20490520
Shitama T, Kiyama T, Naito M, Shiramizu K, Huang G (2009) Which is more invasive-mini versus standard incisions in total hip arthroplasty? Int Orthop 33(6):1543–1547
pubmed: 19148642
pmcid: 2899170
Goosen JH, Kollen BJ, Castelein RM, Kuipers BM, Verheyen CC (2011) Minimally invasive versus classic procedures in total hip arthroplasty: a double-blind randomized controlled trial. Clin Orthop Relat Res 469(1):200–208
pubmed: 20352383
Tottas S, Tsigalou C, Ververidis A, Kougioumtzis IE, Karaglani M, Tilkeridis K, Chatzipapas C, Drosos GI (2020) Supercapsular percutaneously assisted total hip arthroplasty versus lateral approach in total hip replacement. A prospective comparative study. J Orthop 21:406–415
pubmed: 32921949
pmcid: 7476237
Meng W, Gao L, Huang Z, Wang H, Wang D, Luo Z, Bai Y, Wang G, Zhou Z (2021) Supercapsular percutaneously-assisted total hip (SuperPath) versus mini-incision posterolateral total hip arthroplasty for hip osteoarthritis: a prospective randomized controlled trial. Ann Transl Med 9(5):392
pubmed: 33842613
pmcid: 8033341
Meng W, Huang Z, Wang H, Wang D, Luo Z, Bai Y, Gao L, Wang G, Zhou Z (2019) Supercapsular percutaneously-assisted total hip (SuperPath) versus posterolateral total hip arthroplasty in bilateral osteonecrosis of the femoral head: a pilot clinical trial. BMC Musculoskelet Disord 21(1):2
Leunig M, Faas M, von Knoch F, Naal FD (2013) Skin crease ‘bikini’ incision for anterior approach total hip arthroplasty: surgical technique and preliminary results. Clin Orthop Relat Res 471(7):2245–2252
pubmed: 23412730
pmcid: 3676627
Wang Q, Yue Y, Yang Z, Chen L, Li Q, Kang P (2021) Comparison of postoperative outcomes between traditional longitudinal incision and bikini incision in total hip arthroplasty via direct anterior approach: a randomized controlled trial. J Arthroplast 36(1):222–230
Lanting BA, Hartley KC, Raffoul AJ, Burkhart TA, Sommerville L, Martin GR, Howard JL, Johnson M (2017) Bikini versus traditional incision direct anterior approach: is there any difference in soft tissue damage? Hip Int 25;27(4):397–400
Suzuki K, Kawachi S, Sakai H, Nanke H, Morita S (2004) Mini-incision total hip arthroplasty: a quantitative assessment of laboratory data and clinical outcomes. J Orthop Sci 9(6):571–575
pubmed: 16228673
Kwak S, Chun Y, Rhyu K, Cha J, Cho Y (2014) Quantitative analysis of tissue injury after minimally invasive total hip arthroplasty. Clin Orthop Surg 6(3):279–284
pubmed: 25177452
pmcid: 4143514
Xiao C, Gao Z, Zhang S, Long N, Yao K, Cai P, He F, Liu L, Jiang Y (2021) Comparative prospective randomized study of minimally invasive transpiriformis approach versus conventional posterolateral approach in total hip arthroplasty as measured by biology markers. Int Orthop 45(7):1707–1717
pubmed: 34043029
Fink B, Mittelstaedt A, Schulz MS, Sebena P, Singer J (2010) Comparison of a minimally invasive posterior approach and the standard posterior approach for total hip arthroplasty a prospective and comparative study. J Orthop Surg Res 27(5):46
Xuan TD, Trung DT, Gia DH, Minh DN (2019) Changes of the serum creatine phosphokinase in total hip arthroplasty in Vietnamese patients. J Arthrosc Joint Surg 6(3):180–183. https://doi.org/10.1016/j.jajs.2018.11.005
doi: 10.1016/j.jajs.2018.11.005
Mazoochian F, Weber P, Schramm S, Utzschneider S, Fottner A, Jansson V (2009) Minimally invasive total hip arthroplasty: a randomized controlled prospective trial. Arch Orthop Trauma Surg 129(12):1633–1639
pubmed: 19424709
Dienstknecht T, Luring C, Tingart M, Grifka J, Sendtner E (2014) Total hip arthroplasty through the mini-incision (Micro-hip) approach versus the standard transgluteal (Bauer) approach: a prospective, randomised study. J Orthop Surg (Hong Kong) 22(2):168–172
Mouilhade F, Matsoukis J, Oger P, Mandereau C, Brzakala V, Dujardin F (2011) Component positioning in primary total hip replacement: a prospective comparative study of two anterolateral approaches, minimally invasive versus gluteus medius hemimyotomy. Orthop Traumatol Surg Res 97(1):14–21
pubmed: 21236746
Cohen RG, Katz JA, Skrepnik NV (2009) The relationship between skeletal muscle serum markers and primary THA: a pilot study. Clin Orthop Relat Res 467(7):1747–1752
pubmed: 19326181
pmcid: 2690757
van Oldenrijk J, Hoogland PV, Tuijthof GJ, Corveleijn R, Noordenbos TW, Schafroth MU (2010) Soft tissue damage after minimally invasive THA. Acta Orthop 81(6):696–702
pubmed: 21110702
pmcid: 3216079
Meneghini RM, Pagnano MW, Trousdale RT, Hozack WJ (2006) Muscle damage during MIS total hip arthroplasty: Smith-Petersen versus posterior approach. Clin Orthop Relat Res 453:293–298
pubmed: 17006366
Frye BM, Berend KR, Lombardi AV Jr, Morris MJ, Adams JB (2015) Do sex and BMI predict or does stem design prevent muscle damage in anterior supine minimally invasive THA? Clin Orthop Relat Res 473(2):632–638
pubmed: 25337974
Bremer AK, Kalberer F, Pfirrmann CW, Dora C (2011) Soft-tissue changes in hip abductor muscles and tendons after total hip replacement: comparison between the direct anterior and the transgluteal approaches. J Bone Joint Surg Br 93(7):886–889
pubmed: 21705558
Yoon SI, Lim SS, Rha JD, Kim YH, Kang JS, Baek GH, Yang KH (1993) The C-reactive protein (CRP) in patients with long bone fractures and after arthroplasty. Int Orthop 17(3):198–201
pubmed: 8340178
Schlattner U, Tokarska-Schlattner M, Wallimann T (2006) Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762(2):164–180
pubmed: 16236486
Sayers S, Clarkson P (2003) Short-term immobilization after eccentric exercise. Part II: Creatine kinase and myoglobin. Medicine Sci Sports Exerc 35:762–768
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812
pubmed: 12813013
pmcid: 161431
Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci 20(23):6008
Baggiolini M, Clark-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 27;307(1):97–101.
Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 4;6(10):a016295.
Saraiva M, Vieira P, O'Garra A (2020) Biology and therapeutic potential of interleukin-10. J Exp Med 217(1):e20190418